Panagiota Ioannidou

OS-068-YI The new EASL treatment indications for HBeAg-negative chronic hepatitis B virus infection reduce grey-zone patients and reflect better routine clinical practice

Μargarita Papatheodoridi, Sofia Paraskevopoulou, Panagiota Ioannidou, Paraskevi Fytili et autres

THU-172 Eligibility for resmetirom or semaglutide therapy in a real-life Greek cohort of patients with metabolic associated steatotic liver disease

Μargarita Papatheodoridi, Antonia Neonaki, Alexandra Argyrou, Stratigoula Sakellariou et autres

Long-term outcomes of baseline grey-zone patients with HBeAg-negative chronic hepatitis B virus infection

Μargarita Papatheodoridi, Sofia Paraskevopoulou, Panagiota Ioannidou, Paraskevi Fytili et autres

BACKGROUND & AIMS: The optimal management and outcomes of patients with HBeAg-negative grey-zone (GZe-) chronic HBV infection remain debatable. We assessed the outcomes and real-life management of GZe-patients and compared them to patients with typical HBeAg-negative chronic infection (CIe-). METHODS: We included …

gr (code pays fourni par la source)

SAT-300 The effect of antiviral therapy on the outcomes of baseline grey- zone (GZ) patients with HBeAg-negative chronic hepatitis B virus infection (CHBVe-)

Μargarita Papatheodoridi, Sofia Paraskevopoulou, Panagiota Ioannidou, Paraskevi Fytili et autres

SAT-420 Natural explant with dihydromiricetin in metabolic associated steatotic liver disease (ΜASLD): a double-blind, placebo controlled, randomized clinical trial

Elisavet Michailidou, Stavros P. Papadakos, Eleni Koukoulioti, Maria Graziella Mela et autres

Incidence of primary hepatitis C infection among people who inject drugs during 2012–2020 in Athens, Greece

Sotirios Roussos, Christos Bagos, Theodoros P. Angelopoulos, Savvas Chaikalis et autres

One of the World Health Organization's targets for the 2030 viral hepatitis elimination strategy is to reduce new hepatitis C (HCV) infections. In Athens, Greece, people who inject drugs (PWID) have a high HCV prevalence, with increasing trends since the 2000s. This …

gr, gb (code pays fourni par la source)

High levels of all-cause mortality among people who inject drugs from 2018 to 2022

Sotirios Roussos, Theodoros P. Angelopoulos, Εvangelos Cholongitas, Spyridon Savvanis et autres

gr (code pays fourni par la source)

HERACLIS‐HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg ‐positive patients

George Papatheodoridis, Konstantinos Mimidis, Spilios Manolakopoulos, Christos K Triantos et autres

BACKGROUND AND AIMS: Hepatitis D virus (HDV) underdiagnosis remains common. We assessed the HDV screening and prevalence rates in HBsAg-positive patients seen at tertiary liver centres throughout Greece as well as factors affecting HDV diagnosis. METHODS: All adult HBsAg-positive patients seen within …

gr (code pays fourni par la source)

Prevalence and predictors of HDV viremia in anti-HDV positive patients of the HEllenic multicenter ReAl-life CLInical Study (HERACLIS-HDV)

George Papatheodoridis, Spilios Manolakopoulos, Stylianos Karapatanis, Ioannis S Elefsiniotis et autres

High levels of all-cause mortality among people who inject drugs in Greece in 2018–2022

Sotirios Rousssos, Theodoros P. Angelopoulos, Εvangelos Cholongitas, Spyridon Savvanis et autres

ABSTRACT Aims To estimate all-cause mortality in a cohort of people who inject drugs (PWID) over the period 2018–2022 in the two major cities of Greece (Athens and Thessaloniki). Methods PWID were recruited from two community-based seek-test-treat programs for HCV and HIV …

gr (code pays fourni par la source)

Comparative Utility of Transient and 2D Shear Wave Elastography for the Assessment of Liver Fibrosis in Clinical Practice

Dimitrios S. Karagiannakis, Theodoros A. Voulgaris, Theodoros P. Angelopoulos, Panagiota Ioannidou et autres

gr (code pays fourni par la source)

Assessment of dietary habits and the adequacy of dietary intake of patients with cirrhosis-the KIRRHOS study

Alexandra Georgiou, Mary Yannakoulia, Melanie J. Deutsch, Αlexandra Alexopoulou et autres

gr (code pays fourni par la source)